Open AccessSingle-Step Rapid Diagnosis of Dopamine and Serotonin Metabolism Disorders
Author(s) -
Aurélien Lo,
Pierre Guibal,
Diane Doummar,
Diana Rodriguez,
Jean-Yves Hautem,
Rémy Couderc,
Thierry Billette de Villemeur,
Emmanuel Roze,
Pierre Chaminade,
Fathi Moussa
Publication year - 2017
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.7b01008
Subject(s) - monoamine neurotransmitter , dopamine , serotonin , neurotransmitter , cerebrospinal fluid , chemistry , chromatography , high performance liquid chromatography , medicine , biochemistry , receptor
Early diagnosis of dopamine and serotonin metabolic defects is of importance notably because of the availability of therapeutic strategies able to prevent the associated progressive brain dysfunction. The diagnosis of these diseases relies on the determination of monoamine metabolites and pterins in cerebrospinal fluid (CSF). Current methods involve at least two high-performance liquid chromatography runs of CSF analysis. The first one is devoted to the quantification of dopamine and serotonin metabolites and the second one to the quantification of pterins. Here, we describe a single-step method to measure monoamine neurotransmitter metabolites and pterins of interest in less than 10 min by ultrahigh-performance liquid chromatography coupled to sequential coulometric oxidation and fluorescence detections. All target compounds were quantified in CSF with a small volume (50 μL) and a single filtration step for sample preparation and analysis. After validation, the proposed method was applied to the determination of age-related reference ranges in the CSF of target compounds from a series of 1372 samples collected in France from 2008 to 2014. In the same period, the results obtained for 19 CSF samples from patients with known neurotransmitter disorders and 115 CSF samples with known immune system activation confirmed the expected pattern of changes in monoamine metabolites and pterins.